Amnicell Corp

Amnicell Corp, based in New York, NY, specializes in the development of off-the-shelf human stem cell therapies using naturally pluripotent amniotic fluid stem cells. Founded on over a decade of pioneering research by Dr. Bruce K. Young, the company has created a patented process that allows for the rapid collection and processing of stem cells, enabling direct clinical use within 48 hours.

The leadership team comprises seasoned professionals, including biotech veterans and legal experts, all committed to commercializing innovative stem cell therapies without the need for genetic modification. Their approach significantly lowers risks and costs for patients, positioning Amnicell as a leading authority in the field of regenerative medicine.

Generated from the website